flanders.bio member events

Patient centricity in Clinical Research

The development of new therapies and treatments has evolved quickly over the last few years. Clinical trial requirements are more complex and demanding, not only for the industry developing the new medications, but also for patients participating in the clinical trials.

8 Mar 2018

-

9 Mar 2018

Applied Bioinformatics in Life Sciences (2nd edition)

As an integral part of biological research, the field of bioinformatics brings forth innovative computational approaches leading to high-impact results in an increasingly data-dense environment.

14 Mar 2018

-

15 Mar 2018

Rousselot innovation days 2018

Invitation to the Rousselot Innovation Days 2018 at the Expertise Center in Ghent, Belgium. 

The theme of the two-day event, ‘New perspectives in the pharma- & nutraceutical world’, offers you the perfect opportunity to explore new opportunities, gain new insights and grow your business.

15 Mar 2018

-

16 Mar 2018

Laborama 2018

Laborama Expo is the all-encompassing trade fair for the laboratory sector in Belgium and Luxembourg. With more than 100 exhibitors, visitors will find not only companies that focus on analytical equipment, but suppliers of software, clean rooms, consumables, furniture, reagents, and more.

22 Mar 2018

MEDTECH MEETUP 2018

MEDICAL DEVICES IN THE SPOTLIGHT

29 Mar 2018

Seminar: How Real World Data will change your clinical development to the better

With today's technology, electronic data are coming from everywhere: social media, smart phones, activity trackers, electronic health records, insurance claim databases, patient registries, health surveys. This Real World Data (RWD) is having a huge impact on how clinical research is being carried out and we even have not seen the end of it.

29 Mar 2018

Connect met Digital Health Start-ups

Health technology zal een cruciale rol spelen in het betaalbaar houden van onze gezondheidszorg. Innovaties zoals smart health wearables en monitoring gadgets duiken overal op, maar hoe ziet de opkomende industrie er uit?

24 May 2018

-

25 May 2018

Medical Biotechnology

With this conference on Medical Biotechnology VIB will bring together experts in the field to discuss the new developments and future challenges in this field.

6 Jun 2018

Research and innovation on monitoring and control of infectious diseases (One Health)

STAR-IDAZ.be, the representation of Belgium in STAR-IDAZ IRC, together with Flanders Vaccine and Enterprise Europe Network Vlaanderen join forces to organize an event to stimulate collaboration between researchers in the field of monitoring and control of infectious diseases (One Health approach). This matchmaking event will offer participants the opportunity to expand their network, find potential collaboration partners with the right expertise, and establish new project consortia.

27 Jun 2018

-

29 Jun 2018

SLAS Europe 2018

The first SLAS pan-European meeting at the heart of Europe will take place in Brussels in June 2018. The event will bring together over 1,000 Academic and Industry scientists and technologists from throughout Europe and beyond. Discover a very exciting programme that includes 50 scientific presentations addressing emerging and hot areas in Biology, Technology and Discovery.
The conference is also a great opportunity to find out about the latest developments in Instrumentation, Assays, Diagnostics, etc.

20 Sep 2018

-

21 Sep 2018

Structural Dynamics in Cellular Communication (2nd edition)

This conference will feature current developments in protein science with plenary sessions focusing on macromolecular machines, in situ structural biology, structural engineering & drug discovery and protein function/dynamics.

26 Nov 2018

-

27 Nov 2018

Metabolism in Cancer and Stromal Cells (2nd edition)

During this international Conference we will focus on how cancer and stromal cells metabolically communicate and how their specific metabolism impacts disease development and progression. These cellular metabolism insights will offer novel therapeutic opportunities for malignant, metabolic, or inflammatory disease. In addition, also the impact of ‘omics’ technologies to study cellular metabolism will be highlighted during the meeting.